Publications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (1)

2024

  1. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1